Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3025)
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
22,966
Price
$3.65
Total Value
$83.75K
Shares Held After
67,966
% of Holdings
33.8%
Immunome Inc. (IMNM)
Horn Kinney — CHIEF BUSINESS OFFICER
Shares
90,616
Price
$25.09
Total Value
$2.27M
Shares Held After
0
% of Holdings
100.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
10,292
Price
$68.57
Total Value
$705.72K
Shares Held After
383,868
% of Holdings
2.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.25
Total Value
$97.50K
Shares Held After
6,188,287
% of Holdings
0.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
30,000
Price
$30.48
Total Value
$914.40K
Shares Held After
54,645
% of Holdings
35.4%
Acrivon Therapeutics, Inc. (ACRV)
Levy Adam D. — Chief Financial Officer
Shares
1,142
Price
$1.57
Total Value
$1.79K
Shares Held After
66,008
% of Holdings
1.7%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
83,807
Price
$0.97
Total Value
$81.29K
Shares Held After
4,556,068
% of Holdings
1.8%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
370
Price
$65.77
Total Value
$24.33K
Shares Held After
14,399
% of Holdings
2.5%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
43,947
Price
$2.46
Total Value
$108.10K
Shares Held After
591,815
% of Holdings
6.9%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
26,842
Price
$10.23
Total Value
$274.60K
Shares Held After
844,895
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$520.49
Total Value
$155.63K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$519.50
Total Value
$268.58K
Shares Held After
324,742
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,446
Price
$518.40
Total Value
$749.60K
Shares Held After
325,259
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,142
Price
$517.50
Total Value
$1.63M
Shares Held After
326,705
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,456
Price
$516.59
Total Value
$1.27M
Shares Held After
329,847
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
605
Price
$515.50
Total Value
$311.88K
Shares Held After
332,303
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
675
Price
$514.43
Total Value
$347.24K
Shares Held After
332,908
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
182
Price
$513.39
Total Value
$93.44K
Shares Held After
333,583
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
178
Price
$512.49
Total Value
$91.22K
Shares Held After
333,765
% of Holdings
0.1%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
38,800
Price
$2.46
Total Value
$95.41K
Shares Held After
589,355
% of Holdings
6.2%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
Hepion Pharmaceuticals, Inc. (HEPA)
Appajosyula Sireesh — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
16,250,000
% of Holdings
12.3%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
8,000,000
Price
$0.05
Total Value
$400.00K
Shares Held After
14,250,000
% of Holdings
56.1%
Hepion Pharmaceuticals, Inc. (HEPA)
Purcell Michael J. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. II — Director
Shares
500,000
Price
$0.05
Total Value
$25.00K
Shares Held After
500,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
4,375
Price
$26.12
Total Value
$114.26K
Shares Held After
717,203
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,334
Price
$34.68
Total Value
$80.94K
Shares Held After
96,412
% of Holdings
2.4%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,000
Price
$33.98
Total Value
$33.98K
Shares Held After
98,746
% of Holdings
1.0%
ALUMIS INC. (ALMS)
Goldstein David M — Chief Scientific Officer
Shares
2,596
Price
$26.37
Total Value
$68.46K
Shares Held After
30,970
% of Holdings
7.7%
ALUMIS INC. (ALMS)
Hardiman Roy C. — Chief Business&Strategy Ofcr
Shares
2,692
Price
$26.37
Total Value
$70.99K
Shares Held After
207,746
% of Holdings
1.3%
Showing 1601–1650 of 3025 transactions (page 33 of 61)